Compare CDRE & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDRE | TXG |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2021 | 2019 |
| Metric | CDRE | TXG |
|---|---|---|
| Price | $42.80 | $17.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $34.50 | $14.73 |
| AVG Volume (30 Days) | 289.5K | ★ 3.3M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ 33.82 | N/A |
| EPS | ★ 1.11 | N/A |
| Revenue | $619,068,000.00 | ★ $641,814,000.00 |
| Revenue This Year | $12.51 | $4.50 |
| Revenue Next Year | $8.21 | N/A |
| P/E Ratio | $38.67 | ★ N/A |
| Revenue Growth | ★ 19.94 | 1.92 |
| 52 Week Low | $27.07 | $6.78 |
| 52 Week High | $46.64 | $20.34 |
| Indicator | CDRE | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 57.17 |
| Support Level | $41.56 | $17.06 |
| Resistance Level | $44.08 | $19.29 |
| Average True Range (ATR) | 1.35 | 1.08 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 71.60 | 48.84 |
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).